These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


136 related items for PubMed ID: 2767619

  • 1. Agnogenic myeloid metaplasia (AMM)--correlation of bone marrow lesions with laboratory data: a longitudinal clinicopathological study on 114 patients.
    Thiele J, Zankovich R, Steinberg T, Fischer R, Diehl V.
    Hematol Oncol; 1989; 7(5):327-43. PubMed ID: 2767619
    [Abstract] [Full Text] [Related]

  • 2. Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/-sclerosis (agnogenic myeloid metaplasia)--correlations between clinical and morphological features.
    Thiele J, Hoeppner B, Zankovich R, Fischer R.
    Virchows Arch A Pathol Anat Histopathol; 1989; 415(3):191-202. PubMed ID: 2503923
    [Abstract] [Full Text] [Related]

  • 3. Primary (essential) thrombocythemia versus initial (hyperplastic) stages of agnogenic myeloid metaplasia with thrombocytosis--a critical evaluation of clinical and histomorphological data.
    Thiele J, Zankovich R, Steinberg T, Kremer B, Fischer R, Diehl V.
    Acta Haematol; 1989; 81(4):192-202. PubMed ID: 2474228
    [Abstract] [Full Text] [Related]

  • 4. Myelofibrosis in chronic granulocytic leukaemia.
    Clough V, Geary CG, Hashmi K, Davson J, Knowlson T.
    Br J Haematol; 1979 Aug; 42(4):515-26. PubMed ID: 289409
    [Abstract] [Full Text] [Related]

  • 5. Follow-up studies with sequential bone marrow biopsies in chronic myeloid leukaemia and so-called primary (idiopathic) osteo-myelofibrosis. Evolution of histopathological lesions and clinical course in 40 patients.
    Thiele J, Simon KG, Fischer R, Zankovich R.
    Pathol Res Pract; 1988 Aug; 183(4):434-45. PubMed ID: 3186544
    [Abstract] [Full Text] [Related]

  • 6. Evolution of fibro-osteosclerotic bone marrow lesions in primary (idiopathic) osteomyelofibrosis--a histomorphometric study on sequential trephine biopsies.
    Thiele J, Chen YS, Kvasnicka HM, Diehl V, Fischer R.
    Leuk Lymphoma; 1994 Jun; 14(1-2):163-9. PubMed ID: 7920225
    [Abstract] [Full Text] [Related]

  • 7. Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia).
    Michiels JJ, Thiele J.
    Int J Hematol; 2002 Aug; 76(2):133-45. PubMed ID: 12215011
    [Abstract] [Full Text] [Related]

  • 8. Bone marrow histopathology and biological markers as specific clues to the differential diagnosis of essential thrombocythemia, polycythemia vera and prefibrotic or fibrotic agnogenic myeloid metaplasia.
    Michiels JJ.
    Hematol J; 2004 Aug; 5(2):93-102. PubMed ID: 15048058
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Primary myelofibrosis-osteomyelosclerosis (agnogenic myeloid metaplasia): correlation of clinical findings with bone marrow histopathology and prognosis.
    Thiele J, Steinberg T, Zankovich R, Fischer R.
    Anticancer Res; 1989 Aug; 9(2):429-35. PubMed ID: 2751268
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Morphometric analysis of myelofibrosis in agnogenic myeloid metaplasia and chronic myelogenous leukemia.
    Ohsaka A, Miura Y, Takahashi A, Yokoyama T.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991 Aug; 60(6):399-405. PubMed ID: 1683056
    [Abstract] [Full Text] [Related]

  • 13. Myelosclerosis in agnogenic myeloid metaplasia.
    Feldman F.
    Semin Roentgenol; 1974 Jul; 9(3):195-207. PubMed ID: 4601848
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The syndrome of idiopathic myelofibrosis. A clinicopathologic review with emphasis on the prognostic variables predicting survival.
    Varki A, Lottenberg R, Griffith R, Reinhard E.
    Medicine (Baltimore); 1983 Nov; 62(6):353-71. PubMed ID: 6633248
    [Abstract] [Full Text] [Related]

  • 16. The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome.
    Ward HP, Block MH.
    Medicine (Baltimore); 1971 Sep; 50(5):357-420. PubMed ID: 4940717
    [No Abstract] [Full Text] [Related]

  • 17. Idiopathic primary osteo-myelofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact.
    Thiele J, Kvasnicka HM, Werden C, Zankovich R, Diehl V, Fischer R.
    Leuk Lymphoma; 1996 Jul; 22(3-4):303-17. PubMed ID: 8819080
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of a comprehensive histological evaluation of reticulin fibrosis, collagen deposition and osteosclerosis in primary myelofibrosis patients.
    Gianelli U, Fiori S, Cattaneo D, Bossi A, Cortinovis I, Bonometti A, Ercoli G, Bucelli C, Orofino N, Bulfamante G, Iurlo A.
    Histopathology; 2017 Dec; 71(6):897-908. PubMed ID: 28710830
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Role of Endothelin-1 in a Syndrome of Myelofibrosis and Osteosclerosis.
    Yachoui R, Kristianto J, Sitwala K, Blank RD.
    J Clin Endocrinol Metab; 2015 Nov; 100(11):3971-4. PubMed ID: 26358171
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.